Formulation design and in vivo antimalarial evaluation of lipid-based drug delivery systems for oral delivery of β-arteether

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 82, Issue 1, 2012, Pages 112-119

  Memvanga, Patrick B ^a,b   Préat, Véronique ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b UNIVERSITY OF KINSHASA   (Congo)

Author keywords

Arteether; Antimalarial efficacy; Oral administration; Plasmodium berghei; SEDDS

Indexed keywords

ALCOHOL; ARTEETHER; CREMOPHOR; FAT DROPLET; LACTATE DEHYDROGENASE; POLYSORBATE 80; SESAME SEED OIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIMALARIAL ACTIVITY; ARTICLE; CELL STRAIN CACO 2; CELL VIABILITY; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; DRUG FORMULATION; DRUG SOLUBILITY; DRUG STABILITY; ENZYME ACTIVITY; GASTROINTESTINAL TRACT; IN VIVO STUDY; INTESTINE CELL; MOUSE; NONHUMAN; PEANUT; PLASMODIUM BERGHEI INFECTION;

ADMINISTRATION, ORAL; ANIMALS; ANTIMALARIALS; ARTEMISININS; CACO-2 CELLS; DISEASE MODELS, ANIMAL; DRUG DELIVERY SYSTEMS; DRUG DESIGN; EMULSIONS; EXCIPIENTS; HUMANS; LIPIDS; MALARIA; MICE; PLASMODIUM BERGHEI; SOLUBILITY;

EID: 84866040113     PISSN: 09396411     EISSN: 18733441     Source Type: Journal    
DOI: 10.1016/j.ejpb.2012.05.004     Document Type: Article

References (47)

1. World Malaria Report, WHO Press, Geneva, 2011.
2. R.T. Eastman, and D.A. Fidock Artemisinin-based combination therapies: a vital tool in efforts to eliminate malaria Nat. Rev. Microbiol. 7 2009 864 874
3. The Africa Malaria Report, WHO Press, Geneva, 2003.
4. Guidelines for the Treatment of Malaria, WHO Press, Geneva, 2010.
5. N.J. White Qinghaosu (Artemisinin): the price of success Science 320 2008 330 334
6. U. Eckstein-Ludwig, R.J. Webb, I.D. Van Goethem, J.M. East, A.G. Lee, M. Kimura, P.M. O'Neill, P.G. Bray, S.A. Ward, and S. Krishna Artemisinins target the SERCA of Plasmodium falciparum Nature 424 2003 957 961
7. S.R. Meshnick Artemisinin: mechanisms of action, resistance and toxicity Int. J. Parasitol. 32 2002 1655 1660
8. Who Model List of Essential Medicines, WHO Press, Geneva, 2011.
9. Who Model List of Essential Medicines for Children, WHO Press, Geneva, 2011.
10. Q. Li, C.B. Lugt, S. Looareesuwan, S. Krudsood, P. Wilairatana, S. Vannaphan, K. Chalearmrult, and W.K. Milhous Pharmacokinetic investigation on the therapeutic potential of artemotil (beta-arteether) in Thai patients with severe Plasmodium falciparum malaria Am. J. Trop. Med. Hyg. 71 2004 723 731
11. C. Singh, S. Chaudhary, and S.K. Puri Orally active esters of dihydroartemisinin: synthesis and antimalarial activity against multidrug-resistant Plasmodium yoelii in mice Bioorg. Med. Chem. Lett. 18 2008 1436 1441
12. M.A. Bayomi, A.A. Al-Angary, M.A. Al-Meshal, and M.M. Al-Dardiri In vivo evaluation of arteether liposomes Int. J. Pharm. 175 1998 1 7
13. J.K. Baker, J.D. McChesney, and H.T. Chi Decomposition of arteether in simulated stomach acid yielding compounds retaining antimalarial activity Pharm. Res. 10 1993 662 666
14. M.G. Drew, J. Metcalfe, M.J. Dascombe, and F.M. Ismail Reactions of artemisinin and arteether with acid: implications for stability and mode of antimalarial action J. Med. Chem. 49 2006 6065 6073
15. C.W. Pouton, and C.J. Porter Formulation of lipid-based delivery systems for oral administration: materials, methods and strategies Adv. Drug Deliv. Rev. 60 2008 625 637
16. C.W. Pouton Formulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification system Eur. J. Pharm. Sci. 29 2006 278 287
17. W.N. Charman, C.J. Porter, S. Mithani, and J.B. Dressman Physiochemical and physiological mechanisms for the effects of food on drug absorption: the role of lipids and pH J. Pharm. Sci. 86 1997 269 282
18. R.N. Gursoy, and S. Benita Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs Biomed. Pharmacother. 58 2004 173 182
19. M.J. Lawrence, and G.D. Rees Microemulsion-based media as novel drug delivery systems Adv. Drug Deliv. Rev. 45 2000 89 121
20. F. Seeballuck, E. Lawless, M.B. Ashford, and C.M. O'Driscoll Stimulation of triglyceride-rich lipoprotein secretion by polysorbate 80: in vitro and in vivo correlation using Caco-2 cells and cannulated rat intestinal lymphatic model Pharm. Res. 21 2004 2320 2326
21. C.J. Porter, and W.N. Charman In vitro assessment of oral lipid based formulations Adv. Drug Deliv. Rev. 50 Suppl 1 2001 S127 S147
22. C.J. Porter, N.L. Trevaskis, and W.N. Charman Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs Nat. Rev. Drug Discov. 6 2007 231 248
23. C.J. Porter, C.W. Pouton, J.F. Cuine, and W.N. Charman Enhancing intestinal drug solubilisation using lipid-based delivery systems Adv. Drug Deliv. Rev. 60 2008 673 691
24. C.J. Porter, K.M. Wasan, and P. Constantinides Lipid-based systems for the enhanced delivery of poorly water soluble drugs Adv. Drug Deliv. Rev. 60 2008 615 616
25. S.M. Khoo, A.J. Humberstone, C.J.H. Porter, G.A. Edwards, and W.N. Charman Formulation design and bioavailability assessment of lipidic self-emulsifying formulations of halofantrine Int. J. Pharm. 167 1998 155 164
26. L. Ould-Ouali, A. Arien, J. Rosenblatt, A. Nathan, P. Twaddle, T. Matalenas, M. Borgia, S. Arnold, D. Leroy, M. Dinguizli, L. Rouxhet, M. Brewster, and V. Preat Biodegradable self-assembling PEG-copolymer as vehicle for poorly water-soluble drugs Pharm. Res. 21 2004 1581 1590
27. European Directorate for the Quality of Medicines, seventh ed., European Pharmacopoeia, France, 2011, pp. 535-540.
28. The International Pharmacopoeia, WHO Press, Geneva, 2006.
29. A. des Rieux, E.G. Ragnarsson, E. Gullberg, V. Preat, Y.J. Schneider, and P. Artursson Transport of nanoparticles across an in vitro model of the human intestinal follicle associated epithelium Eur. J. Pharm. Sci. 25 2005 455 465
30. X. Sha, G. Yan, Y. Wu, J. Li, and X. Fang Effect of self-microemulsifying drug delivery systems containing Labrasol on tight junctions in Caco-2 cells Eur. J. Pharm. Sci. 24 2005 477 486
31. J.F. Ryley, and W. Peters The antimalarial activity of some quinolone esters Ann. Trop. Med. Parasitol. 64 1970 209 222
32. D.A. Fidock, P.J. Rosenthal, S.L. Croft, R. Brun, and S. Nwaka Antimalarial drug discovery: efficacy models for compound screening Nat. Rev. Drug Discov. 3 2004 509 520
33. S.M. Khoo, G.A. Edwards, C.J. Porter, and W.N. Charman A conscious dog model for assessing the absorption, enterocyte-based metabolism, and intestinal lymphatic transport of halofantrine J. Pharm. Sci. 90 2001 1599 1607
34. J.M. Fonteneau, P. Klusiewicz, Travaux pratiques de préparation et de conditionnement des médicaments, Porphyre, France, 2008.
35. B.D. Rege, J.P. Kao, and J.E. Polli Effects of nonionic surfactants on membrane transporters in Caco-2 cell monolayers Eur. J. Pharm. Sci. 16 2002 237 246
36. P.P. Constantinides Lipid microemulsions for improving drug dissolution and oral absorption: physical and biopharmaceutical aspects Pharm. Res. 12 1995 1561 1572
37. B.D. Tarr, and S.H. Yalkowsky Enhanced intestinal absorption of cyclosporine in rats through the reduction of emulsion droplet size Pharm. Res. 6 1989 40 43
38. F.S. Nielsen, E. Gibault, H. Ljusberg-Wahren, L. Arleth, J.S. Pedersen, and A. Mullertz Characterization of prototype self-nanoemulsifying formulations of lipophilic compounds J. Pharm. Sci. 96 2007 876 892
39. P. Augustijns, A. D'Hulst, D.J. Van, and R. Kinget Transport of artemisinin and sodium artesunate in Caco-2 intestinal epithelial cells J. Pharm. Sci. 85 1996 577 579
40. Q.G. Li, S.R. Mog, Y.Z. Si, D.E. Kyle, M. Gettayacamin, and W.K. Milhous Neurotoxicity and efficacy of arteether related to its exposure times and exposure levels in rodents Am. J. Trop. Med. Hyg. 66 2002 516 525
41. S.K. Puri, and R. Chandra Plasmodium vinckei: selection of a strain exhibiting stable resistance to arteether Exp. Parasitol. 114 2006 129 132
42. L.M. Kumaratilake, B.S. Robinson, A. Ferrante, and A. Poulos Antimalarial properties of n-3 and n-6 polyunsaturated fatty acids: in vitro effects on Plasmodium falciparum and in vivo effects on P. berghei J. Clin. Invest. 89 1992 961 967
43. M. Krugliak, E. Deharo, G. Shalmiev, M. Sauvain, C. Moretti, and H. Ginsburg Antimalarial effects of C18 fatty acids on Plasmodium falciparum in culture and on Plasmodium vinckei petteri and Plasmodium yoelii nigeriensis in vivo Exp. Parasitol. 81 1995 97 105
44. M. Joshi, S. Pathak, S. Sharma, and V. Patravale Solid microemulsion preconcentrate (NanOsorb) of artemether for effective treatment of malaria Int. J. Pharm. 362 2008 172 178
45. C. Carrillo, M. del Mar Cavia, H. Roelofs, G. Wanten, and S.R. Alonso-Torre Activation of human neutrophils by oleic acid involves the production of reactive oxygen species and a rise in cytosolic calcium concentration: a comparison with n-6 polyunsaturated fatty acids Cell Physiol. Biochem. 28 2011 329 338
46. D.J. Knight, and W. Peters The antimalarial activity of N-benzyloxydihydrotriazines. I. The activity of clociguanil (BRL 50216) against rodent malaria, and studies on its mode of action Ann. Trop. Med. Parasitol. 74 1980 393 404
47. E. Jantratid, N. Janssen, C. Reppas, and J.B. Dressman Dissolution media simulating conditions in the proximal human gastrointestinal tract: an update Pharm. Res. 25 2008 1663 1676